炎症性肠道疾病患者的工作生产力受损:系统性审查和元分析
Michael Youssef1, Nariman Hossein-Javaheri2, Tedi Hoxha1
1Department of Internal Medicine, University of Toronto, Toronto, ON, Canada.
Journal of Crohn's & colitis
|April 22, 2024
概括
炎症性肠病 (IBD) 显著损害工作生产力,导致缺勤和缺席. 及时的医疗疗法和工作场所的住宿对于改善IBD患者的就业结果至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 职业健康 职业健康 职业健康
- 卫生经济学 卫生经济学
背景情况:
- 炎症性肠病 (IBD) 对工作生产力的影响还不清楚.
- 量化IBD患者的工作相关结果和就业数据至关重要.
研究的目的:
- 系统地审查和元分析IBD患者的工作生产力和就业数据.
- 量化缺勤,出席,整体工作损伤以及与IBD相关的间接成本.
主要方法:
- 在多个数据库 (MEDLINE,EMBASE等) 进行系统的文献搜索. 在2023年2月之前.
- 包括对年龄大于18岁的IBD患者的研究.
- 利用工作生产力和活动损害 (WPAI) 问卷,分析了就业,病假和残疾养老金数据.
- 使用随机效应模型进行聚合效应分析.
主要成果:
- 对IBD患者的综合估计:16.4%的缺勤率,35.9%的出席率,39.4%的整体工作障碍,46.0%的非工作活动障碍.
- 间接成本平均为5131.09欧元/患者/年.
- 只有三分之二的IBD患者有工作;三分之一失去工作.
- 在受雇者中,39.5%报告病假,21.3%报告工作残疾,12.3%报告残疾养老金.
结论:
- 患有IBD的人面临着严重的工作损伤和重大间接经济成本.
- 有效的医疗和/或手术疗法可以导致工作生产率的显著提高.
- 工作场所住宿和及时的医疗治疗非常需要,以减轻IBD患者的疾病负担并提高IBD患者的工作成果.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease I: Ulcerative Colitis
173
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
173
Inflammatory Bowel Disease II: Crohn's Disease
227
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
227
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Chronic Bowel Disorders: Introduction
449
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
449
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145


